HTG, Inc.: Series D $15.7M

Posted in I - Series D, Q - 1Q11, R - SOUTH WEST, X - Device (Diagnostic), X - mRNA, X - miRNA, XX - AZ

HTG (Tuscon, AZ) a commercial-stage molecular technology company focused on gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic applications, closed a $15.7M Series D financing. Participants include Novo Ventures, Fletcher Spaght Ventures, Merck Capital Ventures, Solstice Capital and Valley Ventures.

Ulthera, Inc.: Series C $10.5M

Posted in I - Series C, Q - 1Q11, R - SOUTH WEST, X - Device (Aesthetics), XX - AZ

Ulthera (Mesa, AZ) a commercial-stage medical device company focused on ultrasound technology in the aesthetics market, closed a $10.5M Series C financing. Participants include New Enterprise Associates and Apposite Capital.

WebPT, Inc.: Series A $1M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - TeleMedicine, XX - AZ

WebPT (Phoenix, AZ) a commercial-stage web-based electronic medical records systems for physical therapists, closed a $1M Series A financing. Participants include Canal Partners.

DICOM Grid, Inc.: Series A $7.5M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - Bioinformatics, X - Imaging, X - TeleMedicine, XX - AZ

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

Bonovo Orthopedics, Inc.: Series C $10M

Posted in I - Series C, Q - 4Q10, R - SOUTH WEST, X - Device (Spine), XX - AZ

Bonovo Orthopedics (Scottsdale, AZ) a commercial-stage medical device company focused on a diverse platform of spine and joint products, closed a $10M Series C financing. Participants include OrbiMed and Legend Capital.

EndoStim, Inc.: Series B $6M

Posted in I - Series B, Q - 3Q10, R - SOUTH WEST, X - Device (GI), X - Device (Neuromuscular), X- GERD, XX - AZ

EndoStim (Phoenix, AZ) a development-stage medical device company focused on gastrointestinal and neuromuscular disorders, closed a $6M Series B financing. Participants include Santé Ventures, Prolog Ventures, Vectis Healthcare & Life Sciences Fund.

SynCardia Systems, Inc.: Series D $10.3M

Posted in I - Series D, Q - 2Q09, R - SOUTH WEST, X - Device (Cardiology), XX - AZ

SynCardia Systems (Tuscan, AZ) commercial-stage manufacturer of the temporary cardiowest total artificial heart, closed a $10.3M Series D financing. Participants include Highway 12 Ventures.

to top of page...